ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+1.55%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$356M
AUM Growth
+$356M
(-5%)
Cap. Flow
-$6.28M
Cap. Flow
% of AUM
-1.76%
Top 10 Holdings %
Top 10 Hldgs %
26.42%
Holding
172
New
47
Increased
12
Reduced
23
Closed
37
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$12.6M |
| 2 |
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
|
$7.2M |
| 3 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$6.19M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$5.92M |
| 5 |
Qiagen
QGEN
|
$5.17M |
Top Sells
| 1 |
Aldeyra Therapeutics
ALDX
|
$7.59M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$6.09M |
| 3 |
CareDx
CDNA
|
$5.7M |
| 4 |
Haemonetics
HAE
|
$5.22M |
| 5 |
MEI Pharma
MEIP
|
$5.05M |
Sector Composition
| 1 | Healthcare | 81.19% |
| 2 | Financials | 8% |
| 3 | Technology | 1.97% |
| 4 | Industrials | 1.26% |
| 5 | Communication Services | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ocular Therapeutix
OCUL
$2.25B
| $4.84M | 1.34% |
695,000
+139,000
| +25% | +$969K |
|
27
ADMA Biologics
ADMA
$4.03B
| $4.65M | 1.28% |
+3,300,000
| New | +$4.65M |
|
28
Relmada Therapeutics
RLMD
$48.8M
| $4.64M | 1.28% |
+206,000
| New | +$4.64M |
|
29
Verastem
VSTM
$585M
| $4.62M | 1.27% |
2,253,000
| – | – |
|
30
Adicet Bio
ACET
$60.8M
| $4.6M | 1.27% |
263,000
+120,711
| +85% | +$2.11M |
|
31
Travere Therapeutics
TVTX
$1.75B
| $4.38M | 1.21% |
141,000
| – | – |
|
|
KLR
32
DELISTED
Kaleyra, Inc.
KLR
| $4.36M | 1.2% |
433,892
-50,700
| -10% | -$509K |
|
33
Globus Medical
GMED
$7.94B
| $4.26M | 1.17% |
59,000
+20,500
| +53% | +$1.48M |
|
34
Curis
CRIS
$21.5M
| $3.95M | 1.09% |
829,000
| – | – |
|
|
EUCR
35
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
| $3.9M | 1.08% |
400,000
| – | – |
|
|
SYRS
36
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.78M | 1.04% |
1,160,000
-112,412
| -9% | -$366K |
|
37
Glaukos
GKOS
$5.42B
| $3.6M | 0.99% |
+81,000
| New | +$3.6M |
|
|
AVDL
38
Avadel Pharmaceuticals
AVDL
$1.42B
| $3.56M | 0.98% |
440,589
| – | – |
|
39
Xtant Medical Holdings
XTNT
$82.4M
| $3.5M | 0.96% |
6,246,291
-8,167
| -0.1% | -$4.57K |
|
40
Exact Sciences
EXAS
$9.33B
| $3.43M | 0.94% |
+44,000
| New | +$3.43M |
|
|
NVRO
41
DELISTED
NEVRO CORP.
NVRO
| $3.41M | 0.94% |
42,000
-9,000
| -18% | -$730K |
|
|
PROF
42
Profound Medical
PROF
$131M
| $3.37M | 0.93% |
300,000
+65,000
| +28% | +$730K |
|
|
PRDS
43
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $3.27M | 0.9% |
200,000
| – | – |
|
44
Natera
NTRA
$23B
| $3.27M | 0.9% |
35,000
-10,500
| -23% | -$981K |
|
|
SIEN
45
DELISTED
Sientra, Inc.
SIEN
| $3.18M | 0.88% |
+866,000
| New | +$3.18M |
|
46
Cerus
CERS
$251M
| $3.17M | 0.87% |
465,000
-635,000
| -58% | -$4.32M |
|
47
Immunic
IMUX
$79.4M
| $3.03M | 0.84% |
+317,000
| New | +$3.03M |
|
|
RCOR
48
DELISTED
Renovacor, Inc.
RCOR
| $2.99M | 0.83% |
388,845
| – | – |
|
49
KORU Medical Systems
KRMD
$187M
| $2.99M | 0.82% |
995,500
+41,445
| +4% | +$124K |
|
50
InfuSystem Holdings
INFU
$215M
| $2.98M | 0.82% |
+175,000
| New | +$2.98M |
|